Health Care & Life Sciences » Biotechnology | Advanced Proteome Therapeutics Corp.

Advanced Proteome Therapeutics Corp.

Advanced Proteome Therapeutics Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 126.69 M
Public Float
 -
Advanced Proteome Therapeutics Corp.
Stock Exchange Toronto Ventures Stock Exchange
EPS
 CAD0.04
Market Cap
 CAD3.15 M
Shares Outstanding
 19.92 M
Public Float
 -

Profile

Address
BioSquare
Boston Massachusetts 02118
United States
Employees -
Website http://www.advancedproteome.com
Updated 07/08/2019
Advanced Proteome Therapeutics Corp. is a biotechnology company, which engages in the development of anti-cancer therapeutics. It also commercializes technology platform that is intended for the chemical modification of protein therapeutics. The company was founded by Alexander Krantz on December 12, 2005 and is headquartered in Boston, MA.

Financials

View All
Created with Highcharts 5.0.14Advanced Proteome Therapeutics Corp.Net Income. Fiscal year is August-July. All values CAD Thousands.1 0281 0281 2331 2331 0561 0568938939559559489482013201420152016201720180250500750100012501500

William H. Dickie
President, Chief Executive Officer & Director
Alexander Krantz
COO, Secretary, Non-Executive Director & CSO
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.